These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 38811600)

  • 1. Identification of modules and key genes associated with breast cancer subtypes through network analysis.
    Mares-Quiñones MD; Galán-Vásquez E; Pérez-Rueda E; Pérez-Ishiwara DG; Medel-Flores MO; Gómez-García MDC
    Sci Rep; 2024 May; 14(1):12350. PubMed ID: 38811600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
    Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
    Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition.
    Fredlund E; Staaf J; Rantala JK; Kallioniemi O; Borg A; Ringnér M
    Breast Cancer Res; 2012 Jul; 14(4):R113. PubMed ID: 22839103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis.
    Jia R; Li Z; Liang W; Ji Y; Weng Y; Liang Y; Ning P
    World J Surg Oncol; 2020 Oct; 18(1):268. PubMed ID: 33066779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
    BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of genes and pathways involved in breast cancer subtypes through gene expression meta-analysis.
    Jafarinejad-Farsangi S; Moazzam-Jazi M; Naderi Ghale-Noie Z; Askari N; Miri Karam Z; Mollazadeh S; Hadizadeh M
    Gene; 2022 May; 821():146328. PubMed ID: 35181505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
    Kao J; Salari K; Bocanegra M; Choi YL; Girard L; Gandhi J; Kwei KA; Hernandez-Boussard T; Wang P; Gazdar AF; Minna JD; Pollack JR
    PLoS One; 2009 Jul; 4(7):e6146. PubMed ID: 19582160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
    Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
    Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
    Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M
    BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key modules and genes associated with breast cancer prognosis using WGCNA and ceRNA network analysis.
    Yin X; Wang P; Yang T; Li G; Teng X; Huang W; Yu H
    Aging (Albany NY); 2020 Dec; 13(2):2519-2538. PubMed ID: 33318294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen.
    Liu R; Guo CX; Zhou HH
    Cancer Biol Ther; 2015; 16(2):317-24. PubMed ID: 25756514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer.
    Liu R; Lv QL; Yu J; Hu L; Zhang LH; Cheng Y; Zhou HH
    Breast Cancer Res Treat; 2015 Jun; 151(3):607-18. PubMed ID: 25981901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression and DNA methylation analyses suggest that immune process-related ADCY6 is a prognostic factor of luminal-like breast cancer.
    Li W; Sang M; Hao X; Jia L; Wang Y; Shan B
    J Cell Biochem; 2020 Jul; 121(7):3537-3546. PubMed ID: 31886586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.
    Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Holm K; Hegardt C; Gunnarsson H; Fagerholm R; Strand C; Agnarsson BA; Kilpivaara O; Luts L; Heikkilä P; Aittomäki K; Blomqvist C; Loman N; Malmström P; Olsson H; Johannsson OT; Arason A; Nevanlinna H; Barkardottir RB; Borg A
    Breast Cancer Res; 2010; 12(3):R42. PubMed ID: 20576095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of subtype-specific breast cancer surface protein biomarkers via a novel transcriptomics approach.
    Mercatelli D; Formaggio F; Caprini M; Holding A; Giorgi FM
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34750607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
    Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
    Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of co-expression modules and potential biomarkers of breast cancer by WGCNA.
    Jia R; Zhao H; Jia M
    Gene; 2020 Aug; 750():144757. PubMed ID: 32387385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
    Zhu M; Yi M; Kim CH; Deng C; Li Y; Medina D; Stephens RM; Green JE
    Genome Biol; 2011 Aug; 12(8):R77. PubMed ID: 21846369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression of key gene modules and pathways of human breast cancer cell lines.
    Wu Y; Liu F; Luo S; Yin X; He D; Liu J; Yue Z; Song J
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31285391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer.
    Sandhu R; Rivenbark AG; Mackler RM; Livasy CA; Coleman WB
    Int J Oncol; 2014 Feb; 44(2):563-72. PubMed ID: 24297604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.